US Broker Ratings

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 29.71% Upside Potential in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, has caught the attention of investors with its promising growth trajectory and impressive..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 31.25% Potential Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a leader in the biotechnology sector, is capturing investor attention with its promising potential upside of 31.25%. This neuroscience-focused biopharmaceutical company,..

Envista Holdings Corporation (NVST) Stock Analysis: Potential Upside and Strategic Market Position

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California,..

Metsera, Inc. (MTSR) Stock Analysis: Evaluating the Potential -19.15% Downside Amid Healthcare Innovations

Metsera, Inc. (NASDAQ: MTSR) is a key player in the biotechnology sector, focusing on developing innovative treatments for obesity and related diseases. As a clinical-stage company,..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring a 73.61% Potential Upside in the Medical Devices Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the medical devices industry with its innovative solutions in the field of urology. Headquartered in San Jose,..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Promising 21% Potential Upside in the Biotech Arena

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is making waves with its focus on central nervous system (CNS) disorders and rare..

Sotera Health Company (SHC) Investor Outlook: Exploring a 12.8% Potential Upside with Strong Buy Ratings

Sotera Health Company (NYSE: SHC) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotechnology Space with Promising Growth Prospects

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, has been making waves with its strategic focus on rare disorders, offering a beacon..

Alkermes plc (ALKS) Stock Analysis: Exploring a 53% Potential Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, is a notable entity within the healthcare sector, specifically focusing on the specialty and generic drug manufacturing industry...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Healthcare Innovator with 18% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) presents an intriguing opportunity for investors with its robust growth trajectory and strategic positioning in the healthcare sector. Specializing in..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 32% Revenue Growth Powerhouse with Promising Prospects

Investors with an eye on the healthcare sector should take a closer look at TransMedics Group, Inc. (NASDAQ: TMDX), a key player in the medical devices..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing a 9.88% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics...

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA), a biopharmaceutical innovator in the healthcare sector, is attracting attention with its robust focus on RNA therapeutics through its groundbreaking Antibody..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Robust 131.88% Upside Potential Beckons Investors

Telix Pharmaceuticals Limited (TLX) is making significant waves in the biotechnology industry, particularly in the realm of radiopharmaceuticals. As a commercial-stage biopharmaceutical company, Telix is dedicated..

HealthEquity, Inc. (HQY) Stock Analysis: Analyst Consensus Reveals 18% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands out as a compelling investment opportunity within the healthcare sector, specifically in the health information services industry. With a significant market..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 49% Potential Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a healthcare stalwart based in Barcelona, Spain, offers an intriguing opportunity for investors looking to tap into the drug manufacturing industry. With a..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 151.69% Potential Upside

Investors searching for high-potential opportunities in the biotech sector should cast an eye toward Soleno Therapeutics, Inc. (NASDAQ: SLNO). With a market capitalization of $2.42 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a titan in the diagnostics and research industry, is making waves with its innovative cancer screening and diagnostic products. With a..

Glaukos Corporation (GKOS) Stock Analysis: Unveiling a 20.96% Potential Upside Amidst Rapid Revenue Growth

Glaukos Corporation (NYSE: GKOS) stands as a vanguard in the healthcare sector, specifically within the medical devices industry. Based in the United States, this ophthalmic pharmaceutical..

iRhythm Technologies, Inc. (IRTC) Investor Outlook: A Strong Buy with 23.68% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) is gaining significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $5.73 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds